Current research is focused on identifying novel targets within the nucleotide biosynthesis pathways, understanding the interplay between metabolism and cancer progression, and developing dual-target inhibitors that can overcome resistance. Additionally, there is significant interest in personalized medicine approaches to tailor treatments based on the specific metabolic profile of a patient's tumor.
